Profit taking sinks Eleven Biotherapeutics By: MarketMinute.com Stock News April 25, 2016 at 17:11 PM EDT Profit taking weighed down shares of Eleven Biotherapeutics Inc. (Nasdaq: EBIO) 46 cents to close at $1.04.